Pharmaceuticals
Company Overview of Baxter Oncology GmbH
Company Overview
Baxter Oncology GmbH develops, manufactures, markets, and sells pharmaceutical products for the treatment of cancer in Germany and internationally. It offers therapy products for cancer, such as bleomycin, ifosfamide, cyclophosphamide, mesna, miltefosine, and mitoxantrone. Baxter Oncology GmbH was formerly known as ASTA Medica Onkologie GmbH & Co. KG. The company is based in Weiterstadt, Germany. Baxter Oncology GmbH operates as a subsidiary of Baxter Deutschland Holding Gmbh.
Gutenbergstraße 10
Weiterstadt, 64331
Germany
Key Executives for Baxter Oncology GmbH
Similar Private Companies By Industry
| Company Name | Region |
| EDI GmbH | Europe |
| SIFIN Institut für Immunpräparate und Nährmedien GmbH | Europe |
| Pro-tec Medizinische Produkte GmbH | Europe |
| LipoFIT Analytic GmbH | Europe |
| Sartorius Stedim Biotech GmbH | Europe |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Pittsburgh, PA | Research Recruiting AssociationPosted: Apr 10
- Greenfield, IN | Pace Analytical ServicesPosted: May 24
- Redlands, CA | Inventiv HealthPosted: May 24
Sponsored Financial Commentaries
Sponsored Links
To contact Baxter Oncology GmbH, please visit www.baxter-oncology.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
